Exicure Inc.

Exicure Inc. is a biotechnology company that focuses on the development of next-generation nucleic acid therapies. These therapies are designed to target specific genes and receptors involved in a range of medical conditions, with a particular emphasis on cancers and inflammatory diseases. Exicure Inc. operates within the thriving biotech sector, leveraging proprietary technology platforms such as its Spherical Nucleic Acid (SNA) constructs. These platforms enable the company to create treatments that can efficiently penetrate cells and tissues, potentially enhancing the efficacy and safety of therapeutics. Headquartered in Illinois, Exicure Inc. supports the healthcare and pharmaceutical industries by pioneering innovative approaches to disease treatment and management. In the financial market, the company plays a role in driving advancements in personalized medicine and novel drug development, thereby contributing to the growing field of genomics and biotechnology.